A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy

Brigida Eleonora Annicchiarico; Massimo Siciliano; Alfonso Wolfango Avolio; Rita Luciana Grillo; G. Bombardieri

doi:10.1111/j.1365-2036.2007.03295.x

A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy

Brigida Eleonora Annicchiarico
, Massimo Siciliano
, Alfonso Wolfango Avolio
, Rita Luciana Grillo
, G. Bombardieri

Risultato della ricerca: Contributo in rivista › Articolo › peer review

5 Citazioni (Scopus)

Abstract

Persistence of hepatitis C virus (HCV) in serum is assured after any course of antiviral therapy that failed to obtain a sustained virological response.

Lingua originale	Inglese
pagine (da-a)	1039-1046
Numero di pagine	8
Rivista	ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume	25
DOI	https://doi.org/10.1111/j.1365-2036.2007.03295.x
Stato di pubblicazione	Pubblicato - 2007

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

Keywords

Adult
Aged
Antiviral Agents
Case-Control Studies
Drug Therapy, Combination
Female
Hepacivirus
Hepatitis C, Chronic
Humans
Interferon-gamma
Male
Middle Aged
Prospective Studies
RNA, Viral
Recurrence
Ribavirin
Treatment Outcome

Accesso al documento

10.1111/j.1365-2036.2007.03295.x

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{92af912a2b334fd1b8d0a4ab108ce84a,

title = "A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy",

abstract = "Persistence of hepatitis C virus (HCV) in serum is assured after any course of antiviral therapy that failed to obtain a sustained virological response.",

keywords = "Adult, Aged, Antiviral Agents, Case-Control Studies, Drug Therapy, Combination, Female, Hepacivirus, Hepatitis C, Chronic, Humans, Interferon-gamma, Male, Middle Aged, Prospective Studies, RNA, Viral, Recurrence, Ribavirin, Treatment Outcome, Adult, Aged, Antiviral Agents, Case-Control Studies, Drug Therapy, Combination, Female, Hepacivirus, Hepatitis C, Chronic, Humans, Interferon-gamma, Male, Middle Aged, Prospective Studies, RNA, Viral, Recurrence, Ribavirin, Treatment Outcome",

author = "Annicchiarico, \{Brigida Eleonora\} and Massimo Siciliano and Avolio, \{Alfonso Wolfango\} and Grillo, \{Rita Luciana\} and G. Bombardieri",

year = "2007",

doi = "10.1111/j.1365-2036.2007.03295.x",

language = "English",

volume = "25",

pages = "1039--1046",

journal = "ALIMENTARY PHARMACOLOGY \& THERAPEUTICS",

issn = "0269-2813",

publisher = "Blackwell Science Limited:PO Box 88, Oxford OX2 0NE United Kingdom:011 44 1865 776868, 011 44 1865 206038, EMAIL: [email protected], INTERNET: http://www.blackwell-science.com, Fax: 011 44 1865 721205",

}

TY - JOUR

T1 - A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy

AU - Annicchiarico, Brigida Eleonora

AU - Siciliano, Massimo

AU - Avolio, Alfonso Wolfango

AU - Grillo, Rita Luciana

AU - Bombardieri, G.

PY - 2007

Y1 - 2007

N2 - Persistence of hepatitis C virus (HCV) in serum is assured after any course of antiviral therapy that failed to obtain a sustained virological response.

AB - Persistence of hepatitis C virus (HCV) in serum is assured after any course of antiviral therapy that failed to obtain a sustained virological response.

KW - Adult

KW - Aged

KW - Antiviral Agents

KW - Case-Control Studies

KW - Drug Therapy, Combination

KW - Female

KW - Hepacivirus

KW - Hepatitis C, Chronic

KW - Humans

KW - Interferon-gamma

KW - Male

KW - Middle Aged

KW - Prospective Studies

KW - RNA, Viral

KW - Recurrence

KW - Ribavirin

KW - Treatment Outcome

KW - Adult

KW - Aged

KW - Antiviral Agents

KW - Case-Control Studies

KW - Drug Therapy, Combination

KW - Female

KW - Hepacivirus

KW - Hepatitis C, Chronic

KW - Humans

KW - Interferon-gamma

KW - Male

KW - Middle Aged

KW - Prospective Studies

KW - RNA, Viral

KW - Recurrence

KW - Ribavirin

KW - Treatment Outcome

UR - http://hdl.handle.net/10807/37261

U2 - 10.1111/j.1365-2036.2007.03295.x

DO - 10.1111/j.1365-2036.2007.03295.x

M3 - Article

SN - 0269-2813

VL - 25

SP - 1039

EP - 1046

JO - ALIMENTARY PHARMACOLOGY & THERAPEUTICS

JF - ALIMENTARY PHARMACOLOGY & THERAPEUTICS

ER -

A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy

Abstract

OSS delle Nazioni Unite

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo